Application Notes & Case Studies

1. Nectin 4 Biomarker Testing For Oncology Clinical Programs 11/6/2026

   No validated test existed for a key tumor biomarker. See how a tissue-staining assay was built, validated, and scaled to select the right patients for a cancer trial. 

2. Delivering An Early-Phase Autoimmune Trial Across Regions 11/6/2026

   Why do autoimmune trials stall when patients already have working treatments? See how one rare rheumatology study adapted its strategy to keep early-phase enrollment moving.

3. Recruitment Worked. Can Participants Actually Stay In The Study? 11/4/2026

   Enrolling in a clinical trial doesn’t settle how participants will attend future visits. Upfront expenses and recurring travel needs can expose gaps in study support.

4. Streamlining A Complex Phase 2 RTSM Build 10/29/2026

   A complex Phase 2 trial with blinded and open-label paths needed its randomization system fast. See how smart defaults cut sponsor review work and protected the first-patient date.

5. Successful Partnership Advances AML Program To Phase II/III 10/26/2026

   See how strong collaboration rescued a stalled AML study, proved a safer approach to a proven drug class, and turned a Phase I/II partnership into a global Phase II/III trial.

6. Why Early Device Decisions Matter: How Immunovant Accelerated Its Program 10/15/2026

   Deferring autoinjector selection can seem to preserve flexibility, yet it often moves constraints downstream. Integrating the device during Phase IIb changed one program's timeline and removed bridging work.

7. Accelerating Enrollment For Direct-To-Patient Observational Studies 10/14/2026

   Removing the handoff between patient self-screening and enrollment changes what a fully virtual observational study can achieve, from conversion at peak intent to completion rates among participants.

8. Internal Validation Study: Ultra-Low Temperature Labels 10/8/2026

   Clinical trial vials held at ultra-low temperatures need labels that stay put. Three label formats, applied under dry ice conditions, were compared for qualification.

9. Accelerating A Complex Global Cardiovascular Outcomes Trial Via Coordinated Execution 10/8/2026

   Coordinating CRO, clinical supply, and central lab activities from the start shaped how a 1,500-site, 35-country cardiovascular outcomes trial moved ahead of plan on activation and enrollment.

10. The Answer To Advance Your Allogeneic CAR-T Cell Clinical Trial 9/29/2026

    Dozens of assays, a shifting sample analysis plan, and a network of specialty labs: see how coordinated oversight kept an allogeneic CAR-T trial on track.